These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7357546

  • 1. L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMI 6410 human lymphoblastoid cell line.
    Brox LW, Gowans B, Belch A.
    Cancer Res; 1980 Apr; 40(4):1169-72. PubMed ID: 7357546
    [Abstract] [Full Text] [Related]

  • 2. Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes.
    Hansson J, Lewensohn R, Ringborg U.
    Anticancer Res; 1985 Apr; 5(5):471-7. PubMed ID: 4062251
    [Abstract] [Full Text] [Related]

  • 3. Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione.
    Hansson J, Edgren M, Ehrsson H, Lewensohn R, Ringborg U.
    Anticancer Res; 1987 Apr; 7(1):97-104. PubMed ID: 3566189
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q, Bianchi P, Bezwoda WR.
    Anticancer Res; 2000 Apr; 20(4):2561-8. PubMed ID: 10953327
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of melphalan resistance developed in vitro in human melanoma cells.
    Parsons PG, Carter FB, Morrison L, Regius Mary Sister.
    Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526
    [Abstract] [Full Text] [Related]

  • 7. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
    Ducore JM, Erickson LC, Zwelling LA, Laurent G, Kohn KW.
    Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380
    [Abstract] [Full Text] [Related]

  • 8. Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia.
    Panasci L, Henderson D, Torres-Garcia SJ, Skalski V, Caplan S, Hutchinson M.
    Cancer Res; 1988 Apr 01; 48(7):1972-6. PubMed ID: 3349471
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
    Vistica DT, Toal JN, Rabinovitz M.
    Cancer Treat Rep; 1976 Sep 01; 60(9):1363-7. PubMed ID: 1016969
    [Abstract] [Full Text] [Related]

  • 12. Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.
    Ringborg U, Hansson J, Jungnelius U, Lewensohn R, Skog S.
    Anticancer Res; 1990 Sep 01; 10(2A):297-301. PubMed ID: 2346304
    [Abstract] [Full Text] [Related]

  • 13. Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.
    Lewensohn R, Ehrsson H, Hansson J, Ringborg U.
    Anticancer Res; 1991 Sep 01; 11(1):321-4. PubMed ID: 2018366
    [Abstract] [Full Text] [Related]

  • 14. Dependence on treatment time of melphalan resistance and DNA cross-linking in human melanoma cell lines.
    Parsons PG.
    Cancer Res; 1984 Jul 01; 44(7):2773-8. PubMed ID: 6722805
    [Abstract] [Full Text] [Related]

  • 15. Cell cycle arrest and DNA damage after melphalan treatment of the human myeloma cell line RPMI 8226.
    Fernberg JO, Lewensohn R, Skog S.
    Eur J Haematol; 1991 Sep 01; 47(3):161-7. PubMed ID: 1915798
    [Abstract] [Full Text] [Related]

  • 16. Preferential DNA-protein cross-linking by NiCl2 in magnesium-insoluble regions of fractionated Chinese hamster ovary cell chromatin.
    Patierno SR, Sugiyama M, Basilion JP, Costa M.
    Cancer Res; 1985 Nov 01; 45(11 Pt 2):5787-94. PubMed ID: 4053050
    [Abstract] [Full Text] [Related]

  • 17. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
    Belfi CA, Chatterjee S, Gosky DM, Berger SJ, Berger NA.
    Biochem Biophys Res Commun; 1999 Apr 13; 257(2):361-8. PubMed ID: 10198218
    [Abstract] [Full Text] [Related]

  • 18. Evidence for carrier-mediated transport of melphalan by L5178Y lymphoblasts in vitro.
    Goldenberg GJ, Lee M, Lam HY, Begleiter A.
    Cancer Res; 1977 Mar 13; 37(3):755-60. PubMed ID: 837375
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro.
    Papadopoulou MV, Ji M, Khan SH, Bloomer WD.
    Oncol Res; 1999 Mar 13; 11(8):345-57. PubMed ID: 10803738
    [Abstract] [Full Text] [Related]

  • 20. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78.
    Chatterjee S, Hirota H, Belfi CA, Berger SJ, Berger NA.
    Cancer Res; 1997 Nov 15; 57(22):5112-6. PubMed ID: 9371511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.